Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2010-02-28
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
NCT01688102
Maintenance of Vitamin D Level by UVB Radiation
NCT01101243
The Vitamin D Dose-Response Relationship
NCT01074541
Does Sunbed Radiation With Mainly UVA Provoke Cutaneous Vitamin D Synthesis in Humans?
NCT00516867
The Relation Between Vitamin D Production and UVB Exposed Body Surface Area
NCT01042197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UVB
UVB exposed group
Narrowband UVB
UVB 3 times a week
Oral vitamin D tablet
Vitamin D supplementation
Vitamin D and calcium
1 daily tablet of 1600 IU vitamin D3 and 1000 mg calcium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narrowband UVB
UVB 3 times a week
Vitamin D and calcium
1 daily tablet of 1600 IU vitamin D3 and 1000 mg calcium
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 15 or above
Exclusion Criteria
* Ongoing treatment with vitamin D supplementation.
* Intake of light sensitive medicine, such as tetracyclins.
* Skin light eruptions
15 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Bogh
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Åke Svensson, Assoc. Prof., MD, PhD
Role: STUDY_CHAIR
Department of Dermatology, Lund University, Malmoe
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology, Lund University Malmoe
Malmo, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009/687
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.